EverQuote, Inc.
Business
EverQuote operates a leading online marketplace connecting consumers shopping for property and casualty insurance with insurance carriers and agents. The company provides consumer referrals generated through owned websites, call centers, and third-party publisher partnerships, powered by proprietary data and machine learning algorithms. Its two main customer segments are insurance carriers (national and regional) and independent insurance agents, with offerings spanning auto, home, and renters insurance. Revenue derives from performance-based referral fees paid by insurance providers, with consumers receiving free access to the shopping platform.
Summary from 10-K filed 2026-02-24
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 693 | 500 | 288 | 404 | 419 | |
| Cost of revenue | 19 | 21 | 22 | 24 | 24 | |
| Sales and marketing | 541 | 388 | 240 | 349 | 355 | |
| Research and development | 32 | 30 | 28 | 32 | 36 | |
| General and administrative | 34 | 30 | 26 | 28 | 25 | |
| Legal settlement | 8 | — | — | — | — | |
| Restructuring and other charges | — | — | 24 | — | — | |
| Acquisition-related costs | — | — | −150,000 | −4 | 1 | |
| Total cost and operating expenses | 634 | 468 | 340 | 429 | 440 | |
| Income (loss) from operations | 58 | 32 | −52 | −25 | −22 | |
| Interest income | 4 | 2 | 1 | 349,000 | 37,000 | |
| Other income (expense), net | −87,000 | 178,000 | 14,000 | 23,000 | −57,000 | |
| Total other income, net | 3 | 2 | 1 | 372,000 | −20,000 | |
| Income (loss) before income taxes | 62 | 34 | −51 | −24 | −22 | |
| Income tax benefit (expense) | 37 | −2 | −577,000 | — | 3 | |
| Net income (loss) | 99 | 32 | −51 | −24 | −19 | |
| Basic (per share) | 2.75 | 0.92 | −1.54 | −0.77 | −0.67 | |
| Diluted (per share) | 2.63 | 0.88 | −1.54 | −0.77 | −0.67 | |
| Basic (shares) | 36 | 35 | 33 | 31,613 | 29,088 | |
| Diluted (shares) | 38 | 37 | 33 | 31,613 | 29,088 | |
| Foreign currency translation adjustment | 126,000 | −29,000 | 35,000 | −16,000 | 17,000 | |
| Comprehensive income (loss) | 99 | 32 | −51 | −24 | −19 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 171 | 102 | 38 | 31 | 35 | |
| Accounts receivable, net | 75 | 61 | 21 | 30 | 36 | |
| Commissions receivable, current portion | 0 | 3 | 4 | 14 | 9 | |
| Prepaid expenses and other current assets | 10 | 5 | 6 | 7 | 5 | |
| Total current assets | 256 | 172 | 69 | 81 | 85 | |
| Property and equipment, net | 8 | 6 | 6 | 6 | 6 | |
| Goodwill | 22 | 22 | 22 | 22 | 22 | |
| Acquired intangible assets, net | 0 | 3 | 5 | 8 | 10 | |
| Operating lease right-of-use assets | 2 | 3 | 2 | 6 | 7 | |
| Deferred tax assets | 39 | 0 | — | — | — | |
| Commissions receivable, non-current portion | 0 | 4 | 8 | 33 | 13 | |
| Other assets | 183,000 | 320,000 | 29,000 | 450,000 | 681,000 | |
| Total assets | 327 | 211 | 111 | 157 | 144 | |
| Accounts payable | 77 | 60 | 17 | 31 | 30 | |
| Accrued expenses and other current liabilities | 8 | 10 | 9 | 10 | 13 | |
| Deferred revenue | 2 | 2 | 2 | 2 | 2 | |
| Operating lease liabilities | 1 | 1 | 2 | 3 | 3 | |
| Total current liabilities | 87 | 73 | 30 | 45 | 47 | |
| Deferred tax liabilities | 281,000 | 0 | — | — | — | |
| Operating lease liabilities, net of current portion | 1 | 3 | 70,000 | 4 | 6 | |
| Total liabilities | 89 | 75 | 30 | 49 | 58 | |
| Commitments and contingencies (Note 11) | — | — | — | — | — | |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding | — | — | — | — | — | |
| Additional paid-in capital | 320 | 317 | 294 | 270 | 223 | |
| Accumulated other comprehensive income | 126,000 | 0 | 29,000 | −6,000 | 10,000 | |
| Accumulated deficit | −82 | −181 | −213 | −162 | −138 | |
| Total stockholders' equity | 238 | 135 | 81 | 107 | 85 | |
| Total liabilities and stockholders' equity | 327 | 211 | 111 | 157 | 144 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income (loss) | 99 | 32 | −51 | −24 | −19 | |
| Depreciation and amortization expense | 4 | 6 | 6 | 6 | 5 | |
| Stock-based compensation expense | 24 | 21 | 24 | 29 | 30 | |
| Deferred taxes | −38 | — | — | — | −3 | |
| Loss on sale of health assets | — | — | 19 | — | — | |
| Impairment of right-of-use asset | — | — | 384,000 | — | — | |
| Change in fair value of contingent consideration liabilities | — | — | −150,000 | −4 | 196,000 | |
| Provision for bad debt | 10,000 | 13,000 | 204,000 | 693,000 | −41,000 | |
| Unrealized foreign currency transaction (gains) losses | 110,000 | −26,000 | 21,000 | −9,000 | 24,000 | |
| Litigation accrual settled with sale of assets | 8 | — | — | — | — | |
| Accounts receivable | −14 | −40 | 8 | 5 | 11 | |
| Prepaid expenses and other current assets | −4 | 440,000 | 962,000 | −2 | 2 | |
| Commissions receivable, current and non-current | 2 | 5 | 4 | −24 | −17 | |
| Operating lease right-of-use assets | 1 | 2 | 2 | 3 | 3 | |
| Other assets | 137,000 | −291,000 | 421,000 | −19,000 | 534,000 | |
| Accounts payable | 17 | 43 | −13 | 1 | −4 | |
| Accrued expenses and other current liabilities | −2 | 1 | −2 | −2 | 3 | |
| Deferred revenue | −103,000 | −107,000 | 5,000 | −229,000 | 227,000 | |
| Operating lease liabilities | −1 | −3 | −3 | −3 | −3 | |
| Net cash provided by (used in) operating activities | 95 | 67 | −3 | −16 | 7 | |
| Acquisition of property and equipment, including costs capitalized for development of internal-use software | −5 | −4 | −4 | −4 | −3 | |
| Proceeds from sale of health assets | — | — | 13 | — | — | |
| Net cash provided by (used in) investing activities | −5 | −4 | 9 | −4 | −19 | |
| Proceeds from exercise of stock options | 4 | 4 | 979,000 | 942,000 | 4 | |
| Repurchase of common stock | −21 | — | — | — | — | |
| Tax withholding payments related to net share settlement | −4 | −2 | −402,000 | −100,000 | — | |
| Net cash provided by (used in) financing activities | −21 | 2 | 577,000 | 16 | 4 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 3,000 | 1,000 | 18,000 | −27,000 | −6,000 | |
| Net increase in cash, cash equivalents and restricted cash | 69 | 64 | 7 | −4 | −8 | |
| Acquisition of property and equipment included in accounts payable | 125,000 | 135,000 | 25,000 | 60,000 | 100,000 | |
| Assets sold in settlement of litigation accrual | 8 | — | — | — | — | |
| Operating lease liabilities arising from obtaining right-of-use assets | 0 | 4 | 0 | 1 | 383,000 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is EverQuote, Inc.'s CIK number?
EverQuote, Inc.'s SEC CIK number is 0001640428 (1640428). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find EverQuote, Inc.'s SEC filings?
All of EverQuote, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did EverQuote, Inc. last report earnings?
EverQuote, Inc. (EVER) most recently filed an earnings 8-K with the SEC on May 4, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-203961). This is EverQuote, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is EverQuote, Inc.'s most recent earnings 8-K?
EverQuote, Inc.'s latest earnings 8-K (Item 2.02) was filed May 4, 2026 under accession 0001193125-26-203961. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View EverQuote, Inc.'s latest earnings 8-K →
Look up any company's CIK number →